Task: Answer the multiple choice question.
Query: Which compound exhibits a -48.348% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CC(C)c1ccc(C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1
(b) O=C(c1ccco1)N1CCN(c2ccc(Cl)c(Cl)c2)CC1
Answer: a. CC(C)c1ccc(C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)c1ccc(C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1
CC(C)c1ccc(C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1
N-[4-(morpholin-4-ylmethyl)phenyl]-4-propan-2-ylbenzamide